1 |
Ermis M, Falcone N, Roberto de Barros N, Mecwan M, Haghniaz R, Choroomi A, Monirizad M, Lee Y, Song J, Cho HJ, Zhu Y, Kang H, Dokmeci MR, Khademhosseini A, Lee J, Kim HJ. Tunable hybrid hydrogels with multicellular spheroids for modeling desmoplastic pancreatic cancer. Bioact Mater 2023;25:360-73. [PMID: 36879666 DOI: 10.1016/j.bioactmat.2023.02.005] [Reference Citation Analysis]
|
2 |
Padinharayil H, Rai V, George A. Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy. Cancers (Basel) 2023;15. [PMID: 36831413 DOI: 10.3390/cancers15041070] [Reference Citation Analysis]
|
3 |
Mansouri S, Daniel L, Amhis N, Leveille M, Boudreau JE, Alkayyal AA, Collin Y, Tai LH. Perioperative oncolytic virotherapy to counteract surgery-induced immunosuppression and improve outcomes in pancreatic ductal adenocarcinoma. Front Oncol 2023;13:1071751. [PMID: 36874130 DOI: 10.3389/fonc.2023.1071751] [Reference Citation Analysis]
|
4 |
Zhang T, Ren Y, Yang P, Wang J, Zhou H. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Cell Death Dis 2022;13:897. [PMID: 36284087 DOI: 10.1038/s41419-022-05351-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|